Transdermal Hormone Patch Dosing Cycle for Bleeding Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional hormone delivery methods for preventing pregnancy often result in inconvenient dosing regimens and side effects such as hormone-related adverse events and irregular cycle control, particularly breakthrough bleeding, due to the lack of effective and convenient transdermal delivery systems.
Innovation Solution
A transdermal hormone delivery method involving a 4½ to 5 week treatment cycle with a combination of transdermal hormone delivery devices applied for either ½ week or 1 week intervals, followed by rest intervals with reduced hormone dosing, to maintain effective contraception while minimizing side effects.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of operation
If conventional oral hormone delivery is used for 21 days followed by a 7 day rest interval, then the dosing regimen is simple and easy to administer, but the woman experiences withdrawal bleeding and hormone-related side effects
Solution Approach 1:
A transdermal patch delivery system is introduced as an intermediary between the hormone and the body, allowing controlled transdermal absorption that maintains steady serum levels and avoids the abrupt withdrawal associated with oral dosing interruptions. The patch acts as a mediator that provides continuous, controlled delivery without the need for daily administration.
Solution Approach 2:
The delivery method changes from intermittent oral dosing to continuous transdermal delivery, fundamentally altering the pharmacokinetic parameters. This results in maintained steady-state serum hormone levels throughout the treatment cycle, eliminating the withdrawal phase that causes bleeding and side effects while maintaining contraceptive efficacy.
2Reliability
If high dose hormones are administered to ensure effective contraception, then pregnancy prevention is reliable, but hormone-related adverse events and breakthrough bleeding increase
Solution Approach 1:
The transdermal patch provides continuous hormone delivery across the treatment cycle, maintaining steady therapeutic levels that prevent pregnancy while avoiding the peaks and troughs associated with intermittent dosing. This continuous action ensures reliable contraception at lower overall doses, reducing adverse events and breakthrough bleeding.
Solution Approach 2:
The transdermal delivery system utilizes the skin's natural absorptive capabilities to automatically regulate hormone uptake, providing self-regulating delivery that maintains optimal serum levels without requiring high doses. The system leverages the body's own physiological mechanisms for controlled absorption.
3Ease of operation
If transdermal hormone delivery is implemented, then convenient administration and consistent serum levels are achieved, but the device complexity and application requirements increase
Solution Approach 1:
The treatment cycle is segmented into distinct phases (treatment interval and rest interval) with different dosing strategies. During the treatment interval, full-dose patches are applied; during the rest interval, reduced-dose or no patches are used. This segmentation allows convenient administration while managing device complexity through clear, phase-based protocols.
Solution Approach 2:
The dosing regimen is made dynamic by adjusting patch application based on the treatment cycle phase. The system transitions from active treatment patches to reduced or no dosing during the rest interval, allowing the regimen to adapt to physiological needs while maintaining simplicity through clear temporal boundaries.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method provides a convenient and effective contraceptive regimen with reduced side effects by maintaining consistent hormone serum levels, attenuating symptoms of hormone withdrawal, and allowing for flexible patch wear times and dosing adjustments.
Implementation Method 1
transdermally administering an effective amount of a progestin and, optionally, an estrogen
Implementation Method 2
a skin permeation enhancer combination for use therein
Data Source
AI summary
Dosing regimen for transdermal delivery of hormones comprising a 28 day treatment cycle with a fixed treatment interval and a fixed rest interval.